Chinook Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Chinook Therapeutics

07/08/2023 23:28

* Chinook Therapeutics Inc  KDNY.OQ  reported a quarterly
adjusted
loss of 94 cents​​ per share for the quarter ended in June. The
mean expectation of ten analysts for the quarter was for a loss
of 81 cents per share.
    * Revenue rose 141.1% to $1.01 million from a year ago;
analysts
expected $240.00 thousand. 
    * Chinook Therapeutics Inc's reported EPS for the quarter
was a
loss of 94 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Chinook Therapeutics Inc shares had risen by 4.8% this
quarter and gained 53.7% so far this year.
    * The company reported a quarterly loss of $66.94 million.
    * Wall Street's median 12-month price target for Chinook
Therapeutics Inc is $40.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 8
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 7 at 10:27 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.81          -0.94          Missed
 Mar. 31 2023      -0.79          -0.85          Missed
 Dec. 31 2022      -0.79          -0.90          Missed
 Sep. 30 2022      -0.63          -0.83          Missed